L'Italia ha confermato il proprio ruolo di primo piano nel sostegno alla salute globale, annunciando un contributo di 250 milioni di euro a Gavi, the Vaccine Alliance, per il periodo strategico 2026-2030 (Gavi 6.0).
The first cancer vaccines matched to a person's unique tumor neoantigens are forging ahead, with expectations running high as the field awaits results from the first pivotal trial.
Preferences
Would you like to share some personal information with us so we can improve your experience on Researchalize.org?
